
    
      Randomized, , non-inferiority, two parallel arms, 32 weeks, blind for the assessor.

      Subjects should be with inadequate response to methotrexate with stable dosis ≥ 15 and ≤ 25
      mg/week 28 days before randomization.

      Randomization will be 2:1 Enerceptan® to Enbrel® with concomitant medication of MTX
    
  